Myasthenia gravis with a paraneoplastic marker

Journal of Neuro-Ophthalmology

Volumn 20, Issue 2, 2000, Pages 102-105

  Leavitt, Jacqueline A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Lambert Eaton syndrome; Myasthenia gravis; Paraneoplastic syndrome

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR;

ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE MARKER; EATON LAMBERT SYNDROME; HUMAN; MALE; MYASTHENIA GRAVIS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PTOSIS;

EID: 0034122286     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041327-200020020-00008     Document Type: Article

References (43)

1. Weinberg DA, Lesser RL, Vollmer TL. Ocular myasthenia: a protean disorder. Surv Ophthalmol 1994;39:169-210.
2. Elmqvist D, Lambert EH. Detailed analysis of neuromuscular transmission in a patient with the Myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc 1968; 43:689-713.
3. Cruciger MP, Brown B, Denys EH, et al. Clinical and subclinical oculomotor findings in the Eaton-Lambert syndrome. J Clin Neuroophthalmol 1983;3:19-22.
4. Oh SJ. The Eaton-Lambert syndrome in ocular Myasthenia Gravis. Arch Neurol 1974;31:183-6.
5. Lennon VA. Serologic profile of Myasthenia Gravis and distinction from the Lambert-Eaton Myasthenic syndrome. Neurology 1997;48(suppl 5):23-7.
6. Cogan DG. Internuclear ophthalmoplegia, typical and atypical. Arch Ophthal 1970;84:583-9.
7. Cogan DG, Wray SH. Internuclear ophthalmoplegia as an early sign of brain stem tumors. Neurology 1970;20:629-33.
8. Gonyea EF. Bilateral internuclear ophthalmoplegia: association with occlusive cerebrovascular disease. Arch Neurol 1974;31:68-73.
9. Nishizaki T, Tamaki N, Nishida Y, et al. Bilateral internuclear ophthalmoplegia due to hydrocephalus: a case report. Neurosurg 1985;17:822-5.
10. Rich JR, Gregorius KF, Hepler RS. Bilateral internuclear ophthalmoplegia after trauma. Arch Ophth 1974;92:66-8.
11. Jammes JL. Bilateral internuclear ophthalmoplegia due to acute cervical hyperextension without head trauma. J Clin Neuroophthalmol 1989;9:112-4.
12. Cogen MS, Kline LB, Duvall ER. Bilateral internuclear ophthalmoplegia in systemic lupus erythematosus. J Clin Neuroophthalmol 1987;7:69-73.
13. Sherman MD, Allinson RW, Obbens EAMT, et al. Internuclear ophthalmoplegia in acquired immunodeficiency syndrome. Ann Ophthalmol 1989;21:294-5.
14. Glaser JS. Myasthenic pseudo-internuclear ophthalmoplegia. Arch Ophthalmol 1966;75:363-6.
15. Metz HS. Myasthenia Gravis presenting as internuclear ophthalmoplegia. J Ped Ophthalmol 1977;14:23-4.
16. Acers TE. Ocular Myasthenia Gravis mimicking pseudointernuclear ophthalmoplegia and variable esotropia. Am J Ophthalmol 1979;88:319-21.
17. Walsh FB, Hoyt WF. Clinical neuro-ophthalmology. 3rd ed. Vol. 2. Baltimore: Williams & Wilkins, 1969: 1283.
18. Spooner JW, Baloh RW. Eye movement fatigue in Myasthenia Gravis. Neurology 1979;29:29-33.
19. Jay WM, Nazarian SM, Underwood DW. Pseudo-internuclear ophthalmoplegia with downshoot in Myasthenia Gravis. J Clin Neuroophthalmol 1987;7:74-6.
20. Ford CS, Cruz J, Biller J, et al. Bilateral internuclear ophthalmoplegia in carcinomatous meningitis. J Clin Neuroophthalmol 1983;3:127-30.
21. Strominger MB, Mincy EJ, Strominger AI, et al. Bilateral internuclear ophthalmoplegia with absence of convergent eye movements: clinicopathologic correlation. J Clin Neuroophthalmol 1986;6:58-65.
22. Pillay N, Gilbert JJ, Ebers GC, et al. Internuclear ophthalmoplegia and "optic neuritis": paraneoplastic effects of bronchial carcinoma. Neurology 1984:34;788-91.
23. Clark CV, Newsom-Davis J, Sanders MD. Ocular autonomic nerve function in Lambert-Eaton Myasthenic syndrome. Eve 1990;4: 473-81.
24. Osserman KE, Kaplan LI. Rapid diagnostic test for Myasthenia Gravis: increased muscle strength, without fasiculations, after intravenous administration of edrophonium (Tensilon) chloride. JAMA 1952;150:265-8.
25. Retzlaff JA, Kearns TD, Howard FM, et al. Lancaster red-green test in evaluation of edrophonium effect in Myasthenia Gravis. Am J Ophthalmol 1969;67:13-21.
26. Younge BR, Bartley GB. Lancaster test with Tensilon for Myasthenia. Arch Neurol 1987;44:472-3.
27. Moorthy G, Behrens MM, Drachman DB, et al. Ocular pseudomyasthenia or ocular myasthenia "plus": a warning to clinicians. Neurology 1989;39:1150-4.
28. Dirr LY, Donofrio PD, Patton JF, et al. A false-positive edrophonium test in a patient with a brainstem glioma. Neurology 1989; 39:865-7.
29. Oh SJ, Cho HK. Edrophonium responsiveness not necessarily diagnostic of Myasthenia Gravis. Muscle Nerve 1990;13:187-91.
30. Khan GA, Bank N. Interpretation of positive edrophonium (Tensilon) test in patients with end-stage renal disease. Renal Failure 1995;17:65-71.
31. Dell'Osso LF, Ayyar DR, Daroff RB, et al. Edrophonium test in Eaton-Lambert syndrome: quantitative oculography. Neurology 1983;33:1157-63.
32. Brown W, Bolton B. Clinical electromyography. 2nd ed. Boston: Butterworth-Heinemann, 1993:637.
33. Kelly JJ, Daube JR, Lennon VA, et al. The laboratory diagnosis of mild Myasthenia Gravis. Ann Neurol 1982;12:238-42.
34. Harper CM. Electromyographic findings in specific endplate diseases. In: Engel AG, ed. Myasthenia Gravis and Myasthenic disorders. New York: Oxford University Press, 1999:75.
35. Newsom-Davis J, Lang B. The Lambert-Eaton Myasthenic syndrome. In: Engel AG, ed. Myasthenia Gravis and myasthenic disorders. New York: Oxford University Press, 1999:205-28.
36. Lennon VA. Serological diagnosis of Myasthenia Gravis and the Lambert-Eaton Myasthenic syndrome. In: Lisak, RP. Handbook of Myasthenia Gravis and Myasthenic syndromes. New York: Marcel Dekker, Inc., 1994.
37. Lennon VA, Lambert EH, Whittingham S, et al. Autoimmunity in the Lambert-Eaton Myasthenic Syndrome. Muscle Nerve 1982;(suppl 5):21-5.
38. Leys K, Lang B, Johnston I, et al. Calcium channel autoantibodies in the Lambert-Eaton Myasthenic syndrome. Ann Neurol 1991;29: 307-14.
39. Lennon VA, Lambert EH. Autoantibodies bind solubilized calcium channel-conotoxin complexes from small cell lung carcinoma: a diagnostic aid for Lambert-Eaton Myasthenic syndrome. Mayo Clin Proc 1989;64:1498-1504.
40. Vincent A, Lang B, Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton Myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989; 12:496-502.
41. Oguro-Okano M, Griesmann GE, Wieben ED, et al. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992;67:1150-9.
42. Lennon VA, Kryzer TJ, Griesmann GE, et al. Calcium-channel antibodies in the Lambert-Eaton Syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332:1467-74.
43. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton Myasthenic syndrome. J Neurol Sci 1997;147:35-42.